1. Monitoring the scale-up of antiretroviral therapy programmes: methods to estimate coverage
- Author
-
Boerma, J. Ties, Stanecki, Karen A., Newell, Marie-Louise, Luo, Chewe, Beusenberg, Michel, Garnett, Geoff P., Little, Kirsty, Calleja, Jesus Garcia, Crowley, Siobhan, Kim, Jim Yong, Zaniewski, Elizabeth, Walker, Neff, Stover, John, and Ghys, Peter D.
- Subjects
Case studies ,Services ,Health care industry ,Highly active antiretroviral therapy -- Case studies ,Health care industry -- Services -- Case studies - Abstract
Introduction On 1 December 2003, WHO in partnership with UNAIDS launched the '3 by 5' initiative, which aimed to mobilize the world to provide antiretroviral therapy (ART) to 3 million [...], This paper reviews the data sources and methods used to estimate the number of people on, and coverage of, antiretroviral therapy (ART) programmes in low- and middle-income countries and to monitor the progress towards the '3 by 5' target set by WHO and UNAIDS. We include a review of the data sources used to estimate the coverage of ART programmes as well as the efforts made to avoid double counting and over-reporting. The methods used to estimate the number of people in need of ART are described and expanded with estimates of treatment needs for children, both for ART and for cotrimoxazole prophylaxis. An estimated 6.5 million people were in need of treatment in low- and middle-income countries by the end of 2004, including 660 000 children under age 15 years. The mid-2005 estimate of 970 000 people receiving ART in low- and middle-income countries (with an uncertainty range 840 000-1 100 000) corresponds to a coverage of 15% of people in need of treatment. Keywords Antiretroviral therapy, Highly active; HIV infections/epidemiology/drug therapy; Data collection/methods; Needs assessment; Trimethoprim-sulfamethoxazole combination; Developing countries (source: MeSH, NLM). Mots cles Therapie antiretrovirale hautement active; Infection a VIH/epidemiologie/chimiotherapie; Collecte donnees/methodes; Evaluation besoins; Trimethoprime-sulfamethoxazole, Association; Pays en developpement (source: MeSH, INSERM). Palabras clave Terapia antirretroviral altamente activa; Infecciones por VIH/epidemiotogia/quimioterapia; Recoleccion de datos/ metodos; Evaluacion de necesidades; Combinacion trimetoprim-sulfametoxazol; Paises en desarrollo (fuente: DeCS, BIREME). [TEXT NOT REPRODUCIBLE IN ASCII.]
- Published
- 2006